U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07861295) titled 'Satavari and Ashoka for Menopause (SAM) Study' on Sept. 01.
Brief Summary: This 12-week randomized, placebo-controlled clinical trial will evaluate the efficacy and safety of a daily oral supplement containing Ashoka Bark and Shatavari in women experiencing menopausal symptoms. Up to 50 participants will be randomized to receive either the active supplement or placebo, with 40 participants expected to complete the study. Participants will attend visits at Weeks 0, 6, and 12, where hormone levels (FSH and estradiol), menopausal symptoms, quality of life, anxiety, cognitive function, and sleep will be assessed using validated measures....